Cyproterone Acetate with Ethinylestradiol
Cyproterone Acetate with Ethinylestradiol

1.03
A clinical formulation indicated for Women's Health. This combination assists with the management of androgen-sensitive conditions to promote regulated hormonal balance.


Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Cyproterone Acetate, Ethinylestradiol
Reference Brand
Diane-35
Product Origin
Generic Product
Reference Manufacturer
Bayer
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Women's Health, Skin Care
Product Category
Antiandrogen / Estrogen Combo
Pharmacological Class
Hormone Combination
Manufacturer Description
Designed to alleviate severe hormonal acne and address excessive hair growth by targeting androgen activity to support skin health and hormonal balance in women.
Mechanism of Action
Cyproterone acetate blocks the action of male hormones that cause acne and hair growth. Ethinylestradiol regulates the cycle and provides additional anti-androgenic effects by increasing protein binding of hormones.
Route of Administration
Oral
Onset Time
3–6 months for skin effect
Duration
24 hours
Contraindications
Thrombosis history, Liver tumors, Severe hypertension, Breast cancer, Pregnancy, Diabetes with vascular issues
Severe Adverse Events
Venous thromboembolism, Stroke, Myocardial infarction, Liver failure, Gallbladder disease, Severe hypertension
Common Side Effects
Breast tenderness, Nausea
Uncommon Side Effects
Headache, Mood changes, Weight gain, Decreased libido, Vaginal spotting
Drug Interactions
Anticonvulsants, Rifampin, Antibiotics, St. John's Wort, Anticoagulants
Pregnancy Safety Warnings
Contraindicated; not for use in pregnancy.
Age Restrictions
For women after onset of puberty.
Storage Guidelines
Store below 25°C protected from light.
Related Products
Drospirenone/Ethinylestradiol, Spironolactone
Information for Cyproterone Acetate with Ethinylestradiol is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
Categories